Remission of Rheumatoid Arthritis and Primary Biliary Cholangitis After Treatment With Tocilizumab
Authors:
- Soraia AzevedoSASoraia Azevedo
- Joana Sousa-NevesJSJoana Sousa-Neves
- Joana Ramos RodriguesJRJoana Ramos Rodrigues
- Daniela PeixotoDPDaniela Peixoto
- José Tavares-CostaJTJosé Tavares-Costa
- Filipa TeixeiraFTFilipa Teixeira
- 1 June 2021
- journal article
- Published by Elsevier in Reumatología Clínica (English Edition)
- Vol. 17 (6) , 364-365
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- New insights and long-term safety of tocilizumab in rheumatoid arthritisTherapeutic Advances in Musculoskeletal Disease, 2018
- Rheumatoid Arthritis and Primary Biliary Cirrhosis: Cause, Consequence, or Coincidence?Arthritis, 2012
- Diagnosis of primary biliary cirrhosisBest Practice & Research Clinical Gastroenterology, 2011
- Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosisScandinavian Journal of Gastroenterology, 2011
- Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION studyAnnals of the Rheumatic Diseases, 2010